Strategies to Prevent Transcatheter Heart Valve Dysfunction in Low Risk Transcatheter Aortic Valve Replacement
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 124 participants.
Also called NCT03557242
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 124 participants
- Registry
-
NCT03557242
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Unknown status
Technical summary
Registry record NCT03557242. Randomized; no masking; primary purpose treatment. Start 2018-07-05 (actual); primary completion 2023-07-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Strategies to Prevent Transcatheter Heart Valve Dysfunction in Low Risk Transcatheter Aortic Valve Replacement
- Condition
- Aortic Stenosis
- Intervention (Device)
- TAVR (transcatheter aortic valve replacement)
- Intervention (Other)
- Warfarin plus Aspirin
- Intervention (Other)
- Aspirin Only
- Lead sponsor
- Medstar Health Research Institute
Record details
- Record id
cardio:ct-nct03557242- Content hash
33d128c8468f8f656580f81cdeca6def27acac902e2a4c53a6666b2fa7398f19